In recent years, many studies have reported that AHNAK2 could be a biomarker for the diagnosis and prognosis of PDAC, ccRCC, thymic carcinogenesis, bladder cancer, gastric cancer, and UM [11–18]. The gene discussed is AHNAK2; the disease is gastric cancer.